Advertisement
Advertisement
May 3, 2021
iVascular’s iCover Covered Stent Receives CE Mark Approval
May 3, 2021—iVascular announced that the company has received CE Mark approval for the iCover balloon-expanding covered stent for treating arteriosclerotic lesions in renal and iliac arteries, and for the treatment of aneurysms and ruptures.
According to the company, iCover incorporates iVascular’s CoverTech technology that attaches the inner and outer expanded polytetrafluoroethylene layers to ensure complete encapsulation. The device features radiopaque markers of the ends of the stent for visibility to facilitate the implantation and post-expansion.
iVascular advised it has started the first evaluations with the iCover.
“The first clinical experiences with iCover are remarkable, demonstrating the good features of the stent,” commented Professor Vicente Riambau, MD, from Hospital Clinic Barcelona in Barcelona, Spain. Prof. Riambau added in the company’s announcement, “iCover stands out for its excellent navigability and flexibility, while the radiopaque tantalum markers on its ends provide better visibility under X-rays, which enhances precision during implantation. With the launch of iCover, iVascular offers a complete portfolio to treat all type of peripheral lesions.”
Advertisement
Advertisement
